CEO pay benchmark · $10B – $200B
Large-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at large-cap companies in the pharmaceutical preparations industry is $14,944,585. That is 14% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$14.9M
Typical range
$12.6M–$20.2M
Companies
19
Average pay ratio
37:1
Vs. full industry
+14%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Large-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 19 | 54 |
| Median CEO pay | $14,944,585 | $13,107,123 |
| Average CEO pay | $34,781,069 | $20,759,020 |
| Middle 50% range | $12.6M–$20.2M | $8.4M–$19.2M |
| Average pay ratio | 37:1 | 150:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Summit Therapeutics Inc.SMMT | Mahkam Zanganeh | $246.0M | $11.5B |
| Roivant Sciences Ltd.ROIV | Matthew Gline | $163.3M | $25.1B |
| ABBOTT LABORATORIESABT | Robert B. Ford | $24.2M | $163.3B |
| BIOMARIN PHARMACEUTICAL INCBMRN | Alexander Hardy | $21.9M | $11.4B |
| VERTEX PHARMACEUTICALS INC / MAVRTX | Reshma Kewalramani | $21.1M | $134.1B |
| MADRIGAL PHARMACEUTICALS, INC.MDGL | Bill Sibold | $19.2M | $12.0B |
| TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA | Richard Francis | $19.2M | $39.8B |
| Jazz Pharmaceuticals plcJAZZ | Renee D. Gala | $19.2M | $14.8B |
| Viatris IncVTRS | Scott A. Smith | $15.3M | $19.2B |
| BridgeBio Pharma, Inc.BBIO | Neil Kumar | $14.9M | $16.6B |
Nearby peer groups